Source:http://linkedlifedata.com/resource/pubmed/id/15488638
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-10-18
|
pubmed:abstractText |
Studies suggest that IL-1beta (encoded by IL-1B gene) is a pro-inflammatory cytokine and potent inhibitor of gastric acid secretion, which is proposed as a key determinant in gastric carcinogenesis. Two potentially functional polymorphisms (C-31T and T-511C) in the IL-1B promoter were suggested to be correlated with alteration of Helicobacter pylori infection and IL-1beta expression and therefore may be associated with risk of gastric cancer. To test the hypothesis that these two polymorphisms are associated with gastric cancer risk, we performed a case-control study of 280 histologically confirmed gastric cancer patients and 258 age, sex frequency-matched cancer-free controls in a Chinese population. Multivariate logistic regression analyses revealed that the risks (adjusted odds ratio [OR] and 95% confidence interval [CI]) associated with the IL-1B variant genotypes were 1.64 (95% CI, 1.01-2.66) for -31TT and 1.52 (95% CI, 0.91-2.54) for -511CC, respectively, compared with their wild-type homozygotes. The risks were significantly more evident in individuals with H. pylori infection (adjusted OR, 2.14; 95% CI, 1.13-4.06 for -31TT; adjusted OR, 2.00; 95% CI, 1.02-3.89 for -511CC), which was consistent with the biological effects of IL-1beta. When we used the haplotype analyses and assumed the IL-1B -31T and -511C as risk alleles, no synergistic effect was found between these two loci. These findings indicate that these two IL-1B promoter variants may contribute to the risk of developing gastric cancer in the Chinese population, especially in individuals with H. pylori infection.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0304-3835
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
215
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15488638-Asian Continental Ancestry Group,
pubmed-meshheading:15488638-Case-Control Studies,
pubmed-meshheading:15488638-Female,
pubmed-meshheading:15488638-Gene Frequency,
pubmed-meshheading:15488638-Genetic Predisposition to Disease,
pubmed-meshheading:15488638-Helicobacter Infections,
pubmed-meshheading:15488638-Helicobacter pylori,
pubmed-meshheading:15488638-Humans,
pubmed-meshheading:15488638-Interleukin-1,
pubmed-meshheading:15488638-Interleukin-1beta,
pubmed-meshheading:15488638-Male,
pubmed-meshheading:15488638-Middle Aged,
pubmed-meshheading:15488638-Peptide Fragments,
pubmed-meshheading:15488638-Polymorphism, Genetic,
pubmed-meshheading:15488638-Promoter Regions, Genetic,
pubmed-meshheading:15488638-Risk,
pubmed-meshheading:15488638-Stomach Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population.
|
pubmed:affiliation |
Department of Epidemiology and Biostatistics, Nanjing Medical University School of Public Health, 140 Hanzhong Road, Nanjing 210029, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|